Antibody-Based Immunotoxins for Colorectal Cancer Therapy

Monoclonal antibodies (mAbs) are included among the treatment options for advanced colorectal cancer (CRC). However, while these mAbs effectively target cancer cells, they may have limited clinical activity. A strategy to improve their therapeutic potential is arming them with a toxic payload. Immun...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Laura Sanz, Raquel Ibáñez-Pérez, Patricia Guerrero-Ochoa, Javier Lacadena, Alberto Anel
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
CRC
Acceso en línea:https://doaj.org/article/3a4561937d03438ab89cf496388960d8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares